- Home
- ELEV vs KFFB Comparison
ELEV vs KFFB Comparison
Compare ELEV & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- KFFB
- Stock Information
- Founded
- ELEV 2019
- KFFB 2005
- Country
- ELEV United States
- KFFB United States
- Employees
- ELEV N/A
- KFFB N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- KFFB Savings Institutions
- Sector
- ELEV Health Care
- KFFB Finance
- Exchange
- ELEV Nasdaq
- KFFB Nasdaq
- Market Cap
- ELEV 18.1M
- KFFB 21.0M
- IPO Year
- ELEV 2021
- KFFB 2005
- Fundamental
- Price
- ELEV $0.32
- KFFB $2.61
- Analyst Decision
- ELEV Buy
- KFFB
- Analyst Count
- ELEV 6
- KFFB 0
- Target Price
- ELEV $2.94
- KFFB N/A
- AVG Volume (30 Days)
- ELEV 750.8K
- KFFB 4.6K
- Earning Date
- ELEV 08-05-2025
- KFFB 05-12-2025
- Dividend Yield
- ELEV N/A
- KFFB N/A
- EPS Growth
- ELEV N/A
- KFFB N/A
- EPS
- ELEV N/A
- KFFB N/A
- Revenue
- ELEV N/A
- KFFB $8,308,000.00
- Revenue This Year
- ELEV N/A
- KFFB N/A
- Revenue Next Year
- ELEV N/A
- KFFB N/A
- P/E Ratio
- ELEV N/A
- KFFB N/A
- Revenue Growth
- ELEV N/A
- KFFB 13.79
- 52 Week Low
- ELEV $0.22
- KFFB $1.96
- 52 Week High
- ELEV $3.77
- KFFB $3.62
- Technical
- Relative Strength Index (RSI)
- ELEV 49.38
- KFFB 51.72
- Support Level
- ELEV $0.29
- KFFB $2.23
- Resistance Level
- ELEV $0.32
- KFFB $2.66
- Average True Range (ATR)
- ELEV 0.02
- KFFB 0.11
- MACD
- ELEV 0.00
- KFFB 0.02
- Stochastic Oscillator
- ELEV 59.01
- KFFB 88.37
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.